Verastem Stock Market Value
| VSTM Stock | USD 6.28 0.51 7.51% |
| Symbol | Verastem |
Will Biotechnology sector continue expanding? Could Verastem diversify its offerings? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Verastem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Verastem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Verastem 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verastem's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verastem.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Verastem on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Verastem or generate 0.0% return on investment in Verastem over 90 days. Verastem is related to or competes with Regenxbio, Absci Corp, MoonLake Immunotherapeuti, Kalvista Pharmaceuticals, Prothena Plc, Ventyx Biosciences, and Olema Pharmaceuticals. Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the ... More
Verastem Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verastem's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verastem upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 5.83 |
Verastem Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verastem's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verastem's standard deviation. In reality, there are many statistical measures that can use Verastem historical prices to predict the future Verastem's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | 2.63 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verastem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Verastem February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 2.64 | |||
| Mean Deviation | 3.66 | |||
| Coefficient Of Variation | (2,105) | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.75 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | 2.63 | |||
| Maximum Drawdown | 29.76 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 5.83 | |||
| Skewness | 1.32 | |||
| Kurtosis | 4.45 |
Verastem Backtested Returns
Verastem owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0475, which indicates the firm had a -0.0475 % return per unit of risk over the last 3 months. Verastem exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verastem's Coefficient Of Variation of (2,105), risk adjusted performance of (0.03), and Variance of 24.75 to confirm the risk estimate we provide. The entity has a beta of -0.0938, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Verastem are expected to decrease at a much lower rate. During the bear market, Verastem is likely to outperform the market. At this point, Verastem has a negative expected return of -0.24%. Please make sure to validate Verastem's value at risk and rate of daily change , to decide if Verastem performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
Verastem has very weak reverse predictability. Overlapping area represents the amount of predictability between Verastem time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verastem price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Verastem price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.39 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Verastem Correlation, Verastem Volatility and Verastem Performance module to complement your research on Verastem. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Verastem technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.